摘要:
The invention identifies and describes proteins that are differentially expressed in platelets resistant to anti- platelet agents such as aspirin (acetylsalicyclic acid) compared to those platelets that are sensitive to such agents. Methods for determining further such differentially expressed proteins and methods for determining an individual's sensitivity to anti-platelet agents, such as aspirin, prior to administration.
摘要:
The invention relates to a method of detecting the coincidence of two biomolecular structures in a solid phase sample, said method comprising: (i) providing a first and a second fusion protein, each fusion protein comprising (a) a detection domain, said detection domain comprising a DNA binding domain; said detection domain capable of binding a cognate specific nucleotide sequence in co-operation with a further detection domain; (b) a recognition domain, said recognition domain capable of binding a target biomolecular structure; and (c) a connector domain; said connector domain being fused at one end to the detection domain and being fused at the other end to the recognition domain; wherein at least two of (a), (b) and (c) are heterologous to one another; wherein the recognition domains of said first and said second fusion proteins are capable of binding to first and second biomolecular structures; (ii) contacting the sample with said first and second fusion proteins; (iii) incubating to allow binding; (iv) removing unbound fusion protein; (v) contacting the sample with nucleic acid comprising said cognate specific nucleotide sequence; (vi) incubating to allow heterotrimeric binding of the nucleic acid; (vii) detecting nucleic acid bound to the sample wherein detection of nucleic acid in step; (vii) indicates that the two biomolecular structures are present coincidentally in said sample.
摘要:
The invention provides a method for aiding the diagnosis or prognostic monitoring of Alzheimer's disease in a subject, said method comprising; providing a sample of blood obtained from said patient; assaying the amount of gelsolin present in said sample; comparing the amount of gelsolin present in said sample to a reference amount of gelsolin present in a sample from a healthy subject,, wherein detection of a gelsolin level in the sample from said patient which is lower than the gelsolin level in the reference sample indicates an increased likelihood of Alzheimer's disease in said patient. Other markers are Cl protease inhibitor and ceruloplasmin. Both blood samples and tissue samples have been investigated.
摘要:
The present invention relates, in one aspect, to a method for determining the severity of a disease attributed to at least one genetic mutation in one or more of the genes encoding haemoglobin polypeptide chains, comprising the steps of: (a) providing a sample from said subject; and (b) determining the presence of one or more diagnostic markers: (i) within a 127kb segment on chromosome 2pl5; (ii) within MYB and/or HBSIL and/or the intergenic region between MYB and HBSIL located on the 6q23 QTL interval; and/or (iii) within one of the chromosomal loci given in Table 14; wherein the presence of said marker(s) in said sample is indicative that the severity of said disease in said subject will be or is less severe in said subject in comparison to a subject that does not possess said marker(s).
摘要:
The present invention provides a system capable of delivering neuronal calcium sensor-1 (NCS-1), or a nucleotide sequence encoding NCS-1 to a target cell, for promoting neurite outgrowth. The system may be used in the manufacture of a pharmaceutical composition for the treatment of a condition such as spinal cord injury.
摘要:
A method of mapping a first interface to a second interface both of an electronic data communication device (16), which first interface enables exchange of data with a first electronic data communication network (13) and which second interface enables exchange of data with a second electronic data communication network (12), the method comprising the steps of: (1) obtaining an address representative of said first interface; (2) generat ing an identifier; (3) storing said identifier and said address representative of said first interface in a memory with a mapping therebetween; (4) outputting said identifier; (5) awaiting receipt of data comprising said identifier and an address representative of said second interface from said electronic data communication device (16) via said second electronic data communication network (12); and (6) if said data is received, said identifier can be used to map said address representative of said first interface to said address representative of said second interface. A method of estimating the number of people within a predetermined range of a particular location, which method comprises the steps of: - (a) using an antenna to listen for electromagnetic communication signals indicative of the presence of one or more remote electronic data communication device likely to be carried about the person of one or more of said people; and (b) providing an electronic output signal from said antenna representative of said presence; which electronic output signal facilitates estimation of the number of people within said predetermined range.
摘要:
Methods and compositions relating to Alzheimer's disease are provided. Specifically, proteins that are differentially expressed in the Alzheimer's disease state relative to their expression in the normal state are provided. Proteins associated with Alzheimer's disease are identified and described. Methods of diagnosis of Alzheimer's disease using the differentially expressed proteins are also provided, as are methods for the identification and therapeutic use of compounds for the prevention and treatment of Alzheimer's disease.
摘要:
Two different RF-frequency ranges or bands are employed viz. at the localisation RF-frequency and at the imaging RF-frequency, respectively. At these respective RF-frequency ranges different types of magnetic resonance signals are acquired. At the localisation RF-frequency a high sensitivity for the position of the interventional device is achieved. At the imaging RF-frequency a high sensitivity for image information, i.e. contrast resolution, of the anatomical structures of the patient to be examined is achieved.
摘要:
A method of deblurring images e.g. from an MRI scan, comprises calculating the distribution of the slope value of the intensities between the pixels in the image, and using a Levy distribution of power factor k of 1 (Cauchy distribution) up to but not inc luding (2) to determine the correction term to be applied.
摘要:
The invention relates to a method for treating a condition in a subject comprising administering an effective amount of an agent to said subject wherein said agent modulates one or more component(s) of the retinoid signalling pathway.